secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptiNose, Inc. (—)
CIK:        0001494650
Form:       8-K
Filed at:   2024-10-08T23:59:59+00:00
Accession:  0001494650-24-000140
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptiNose appoints Terry Kohler as CFO; grants 675K share option and 150K RSUs as inducement
--------------------------------------------------------------------------------

- Terry Kohler appointed CFO effective Oct 7, 2024; previously CFO of Verrica Pharmaceuticals.
- Base salary of $450,000/year, target bonus 45% of salary, eligible for annual equity awards.
- Received inducement grant: option to purchase 675,000 shares at $0.71/share and 150,000 RSUs, both vesting over 4 years.
- One-time special payment of $90,000 payable in March 2025, repayable if employment terminated within 12 months.
- Severance: 12 months base salary without cause/good reason; enhanced benefits upon change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494650/000149465024000140/0001494650-24-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494650/000149465024000140/optn-20241007.htm
  HTML page:      https://secwatch.observer/filing/0001494650-24-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer